NCT04313270View on ClinicalTrials.gov

Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®

RecruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2025

Conditions

Hypercholesterolemia, Familial

Interventions

DRUG

Evolocumab

12 weeks of treatment with Evolocumab

Trial Locations (1)

80131

RECRUITING

Matteo Di Minno, Napoli

All Listed Sponsors

lead

Federico II University

OTHER